 AFP [1] |
FDA Approves Lucentis for Treatment of Diabetic Macular Edema; Mylan … [2]
Proactive Investors USA & Canada Genentech, a member of the Roche Group (PINK:RHHBY), announced Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration for treatment of diabetic macular edema, an eye condition in people with diabetes that causes … FDA approves drug to treat diabetic macular edema [3]Medical Xpress FDA approves Lucentis (ranibizumab injection) for treatment of diabetic … [4]Chem.Info Roche's Lucentis Wins Backing to Treat Diabetic Blindness [5]Bloomberg Medical News Today [6] –Counsel & Heal [7] all 190 news articles » [8] |
More details can be found at www.diabeteshowto.com [9]